A recent study reveals that individuals who come off blockbuster slimming jabs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end traditional lifestyle regimens.
Findings released in a major medical journal demonstrates that while obese people frequently drop a large proportion of their body weight while on the medication, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"People using these treatments must be aware of the risk of rapid weight regain when the treatment is stopped," stated expert Dr. Susan Jebb.
This pace of regain suggests a return to starting weight in about 18 months.
Analyzing Treatments
The research, which looked at dozens of studies involving thousands of participants, compared the outcomes of GLP-1 agonists with conventional dieting.
Scientists point out that people who shed pounds through lifestyle changes alone typically have a less rapid creep back—perhaps 0.1 kg a month—once they finish.
The Reason for the Quick Regain
Experts believe the way of the injections is key to understanding the heightened rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 concentrations several times higher than normal might result in the body to generate a reduced amount of its endogenous hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement results in appetite is unsuppressed, making binge eating a significant risk."
A Chronic Disease?
Health authorities advise the jabs for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.
Many experts argue that, considering the likelihood of relapse, the treatment is often long-term.
This perspective is reinforced by drug manufacturers, who state that the findings "underscore the chronic character of obesity," akin to managing conditions like diabetes.
User Accounts
Users who have stopped the jabs report a intense return of appetite.
"It was like something flipping and I was suddenly ravenous," said one woman.
The struggle is compounded if users have not developed permanent lifestyle or habit changes during therapy.
Significant Interest
Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is higher among females than men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while the jabs are effective agents for shedding pounds, they are not a standalone fix and maintained weight loss relies on combined behavioural changes.
